Importance of SARS-CoV-2 Spike Antibodies and B Cell Reconstitution to Optimize the Prevention Strategy of COVID-19
-
Published:2023-02-01
Issue:
Volume:
Page:jrheum.221282
-
ISSN:0315-162X
-
Container-title:The Journal of Rheumatology
-
language:en
-
Short-container-title:J Rheumatol
Author:
Thomas MarionORCID,
Avouac JérômeORCID
Abstract
Several lines of evidence have shown that rituximab (RTX)-treated patients are at high risk of severe coronavirus disease 2019 (COVID-19).1Thus, health authorities have considered patients receiving RTX as extremely high priority for anti-SARS-CoV-2 vaccination.
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology